ARHGAP29 and breast carcinoma: T-47D-EMT breast carcinoma cells with reduced ARHGAP29 expression showed significantly reduced invasiveness compared with the control group (58.37 cells ± 9.317 cells SEM in % vs. control 100 cells ± 13.82 cells SEM in %; p = 0.0175; n = 18; Figure 2C).